Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0431 versus placebo in adults with type 2 diabetes mellitus inadequately controlled with diet and exercise
2004-000867-92Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing MK-0431 with Placebo (2 arms). Primary endpoints: HbA1c change at 18 weeks and Safety and tolerability. Started Oct 2004; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-000867-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000867-92.